TCS Unveils Agentic AI Platform to Revolutionize Global Drug Development

Tata Consultancy Services (TCS) has launched its new agentic AI platform, TCS ADD™ AgentHub, designed to transform drug development by streamlining clinical trials and pharmacovigilance workflows. The platform promises up to 40% efficiency gains in clinical data management, 30% faster study builds, and 30% cost savings in drug safety case processing.

Key Highlights of TCS ADD™ AgentHub

• Role-based AI agents: Each agent has defined responsibilities, oversight, and auditability, ensuring compliance in highly regulated pharma environments.
• Human + AI Operating Model: AI agents are embedded into enterprise workflows, while humans retain governance and decision-making authority.
• Efficiency gains: Up to 40% improvement in clinical data management activities.
• Automation benefits: Metadata-driven automation reduces clinical study build effort by 30%.
• Cost savings: End-to-end safety case processing costs cut by 30%.
• Quality control reduction: AI-powered safety agents reduce manual quality control effort by up to 50%.

Applications in Drug Development

• Clinical Trials: AI agents assist with study design, protocol digitization, clinical data review, and SDTM transformation.
• Pharmacovigilance: Agents handle individual case safety report intake, medical coding, literature analysis, and safety monitoring.
• Drug Safety: Automated workflows for adverse event reporting and compliance with regulatory standards.

Benefits for Pharma Companies

Feature	Impact
Efficiency Gains	40% faster clinical data management
Study Build Automation	30% reduction in effort
Cost Savings	30% lower safety case processing costs
Quality Control	50% less manual effort
Compliance	Built-in auditability and oversight

Challenges & Risks

• Regulatory compliance: Pharma firms must ensure AI outputs meet strict audit and governance standards.
• Integration hurdles: Legacy systems may slow adoption despite streamlined integration.
• Trust & scalability: Ensuring reliability and transparency of AI agents remains critical for industry-wide acceptance.

Strategic Outlook

TCS positions AgentHub as a scalable, audit-ready AI workforce that can accelerate drug development while improving patient safety. By embedding AI agents into pharma workflows, TCS aims to move towards autonomous enterprise functions, where humans and AI collaborate seamlessly.